-
For MS, German Working Group Details New Standards for Trials
According to a German working group, trials testing new immunotherapies for MS should focus more on patients’ experiences and symptoms relevant to them. Find out why here.
What do you think? Do you agree with the German working group?
Sorry, there were no replies found.
Log in to reply.